Skip to Main Content

Paper Details

Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer-Reply.
JAMA Oncol
1
2022
Author NameAffiliation
Roy S HerbstYale School of Medicine, Yale Cancer Center, Smilow Cancer Hospital at Yale-New Haven
  • 1 - 1

Datasets

Release 1.2